AMCR vs BIO · P/E 18, rev $23.51B vs rev $651.0M
Amcor PLC (AMCR) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
BIO (BIO) common stock.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. BIO currently screens at market cap $0.
Not investment advice. Open the AMCR and BIO stock pages for the full models.
Not investment advice.